FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine and can be used as a hepatotrophic, lipotropic agent in gastroenterology, as well as for treating cardiac and cerebral atherosclerosis, in neurology in the lower extremity artery diseases (endarteritis). The agent contains tabletted powders of diisopropylammonium dichloroacetate, microcrystalline cellulose, lactose and excipients presented by Aerosil, Primogel and calcium stearyl fumarate.
EFFECT: agent possesses no toxicity, has the high adsorption properties, the apparent anti-inflammatory action, and provides metabolism and the liver regeneration.
3 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
HEPATOPROTECTIVE PROBIOTIC AGENT | 2006 |
|
RU2310463C1 |
MEMBRANE-STABILIZATION AND ANTIOXIDANT MEDICINAL AGENT | 1985 |
|
RU2006224C1 |
COMPOSITION FOR CORRECTION OF DYSLIPIDEMIA AND MAINTENANCE OF FUNCTIONAL STATE OF HUMAN BODY IN METABOLIC SYNDROME | 2018 |
|
RU2681853C1 |
METHOD FOR PROTECTING ISCHEMIZED LIVER | 2004 |
|
RU2269348C1 |
PREPARATION OF RESTORATIVE AND TONIC ACTION | 2000 |
|
RU2162702C1 |
APPLICATION OF L-LYSINE TIAZOTOTATE AS AN ACTIVE BASIS FOR MEDICINES OF HEPATOPROTECTIVE AND DETOXICATIVE ACTION | 2018 |
|
RU2679447C1 |
METHOD OF TOXIC LIVER DAMAGE REDUCTION | 2007 |
|
RU2342132C2 |
PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING THYROID HYPOTHYREOSIS | 2018 |
|
RU2708260C1 |
METHOD FOR CORRECTION OF TOXIC DAMAGES CAUSED BY DOXORUBICIN | 2004 |
|
RU2285532C2 |
"CORSILIN" AS HEPATOPROTECTIVE PRODUCT | 2002 |
|
RU2205637C1 |
Authors
Dates
2015-02-10—Published
2012-11-20—Filed